Intensity Therapeutics Inc. Common stock (INTS)
Stock · NASDAQ · Health Care
$3.24as of 10/16/2026
Price chart
Active signals
INTS Signal Track Record
How signals performed across all stocks →What INTS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 17 | -3.2% | 41% | September 29, 2026 |
| Volume Spike | 14 | -7.1% | 43% | July 31, 2026 |
| Bollinger Band Breakout | 8 | -9.3% | 38% | August 20, 2026 |
| Any 20-session window (baseline) | -8.7% | 27% |
Computed by MarketWall from daily closing prices since April 16, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About INTS
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 5
Fundamentals
- 1-day range
- $3.35$3.55
- Market cap
- $11.49M
- P/E (trailing)
- —
- P/E (forward)
- -1.70
- EPS (trailing)
- $-4.93
- Dividend yield
- —
- Beta
- 3.02
- Avg. volume
- 26.8K
Forecasts
6 analyst ratings
Intensity Therapeutics Inc. Common stock Competitors
Chosen by industry and closest market cap.
- INTSIntensity Therapeutics Inc. Common stock$3.35▼ 0.89%Market cap $11.49MP/E —$3.1$43.5
- SNTISenti Biosciences Holdings Inc. Common Stock$0.225▼ 14.12%Market cap $11.18MP/E —$0.2399$2.88
- BCDABioCardia Inc. Common Stock$0.92▼ 2.13%Market cap $10.80MP/E —$0.75$1.8
- INABIN8bio Inc. Common Stock$1.11▼ 6.33%Market cap $9.55MP/E —$0.88$2.73
- PASGPassage Bio Inc. Common Stock$3.5▼ 2.78%Market cap $14.11MP/E —$3.29$20
- CRISCuris Inc. Common Stock$0.41▼ 19.61%Market cap $8.59MP/E —$0.5733$33.6
- CELZCreative Medical Technology Holdings Inc. Common Stock$0.741▼ 9.39%Market cap $7.58MP/E —$0.62$6.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| INTS Intensity Therapeutics Inc. Common stock | $11.49M | — | $3.35 | ▼ 0.89% | $3.1$43.5 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | $11.18M | — | $0.225 | ▼ 14.12% | $0.2399$2.88 |
| BCDA BioCardia Inc. Common Stock | $10.80M | — | $0.92 | ▼ 2.13% | $0.75$1.8 |
| INAB IN8bio Inc. Common Stock | $9.55M | — | $1.11 | ▼ 6.33% | $0.88$2.73 |
| PASG Passage Bio Inc. Common Stock | $14.11M | — | $3.5 | ▼ 2.78% | $3.29$20 |
| CRIS Curis Inc. Common Stock | $8.59M | — | $0.41 | ▼ 19.61% | $0.5733$33.6 |
| CELZ Creative Medical Technology Holdings Inc. Common Stock | $7.58M | — | $0.741 | ▼ 9.39% | $0.62$6.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Donovan Daniel · July 16, 2026 · Grant5.5K
- John M. Wesolowski · July 16, 2026 · Grant11.0K
- GOLDBERG MARK A · July 16, 2026 · Grant5.5K
- Lewis H. Bender · July 16, 2026 · Grant78.0K
- DUBIN THOMAS I H · July 16, 2026 · Grant5.5K
- Leahy Emer · July 16, 2026 · Grant5.5K
- Joseph Talamo · July 16, 2026 · Grant34.0K
- John M. Wesolowski · June 30, 2026 · Grant3.7K @ $3.49
- Joseph Talamo · June 30, 2026 · Grant1.1K @ $3.49
Institutional Ownership
March 31, 2026
- Total shares held
- 132.0K
- Total value held
- $775.9K
- Institutional holders
- 11
- Unknown26.0K
- Unknown26.0K
- Unknown25.0K
- Unknown23.3K
- Unknown16.8K
- Unknown14.1K
- Unknown200
- Unknown200
- Unknown192
- Unknown67
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
INTS Joins 12 Health Care Stocks Moving After-Market
Intensity Therapeutics was one of 12 healthcare stocks that moved in Wednesday's after‑market session. The move shows that the stock attracted extra trading after hours, which can affect its price in the next session. The stock is trading near its 13‑touch support level of $4.00 and has a moderate RSI of 44.4. The high‑beta signal suggests it may be more volatile than the broader market.
INTS Joins 12 Health Care Stocks Moving After-Market. Intensity Therapeutics was one of 12 healthcare stocks that moved in Wednesday's after‑market session. The move shows that the stock attracted extra trading after hours, which can affect its price in the next session. The stock is trading near its 13‑touch support level of $4.00 and has a moderate RSI of 44.4. The high‑beta signal suggests it may be more volatile than the broader market.